Medicare Enrolled
Dr. Matthew Meleka, D.O.
Interventional Cardiology · Canton, GA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Meleka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meleka?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Meleka
Dr. Matthew Meleka is an interventional cardiology specialist in Canton, GA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Meleka performed 1,665 Medicare services across 1,206 unique beneficiaries.
Between the years covered by Open Payments, Dr. Meleka received a total of $6,755 from 39 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meleka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ 1,665 Medicare services
$6,755 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,665
Medicare services
Bottom 49% in GA for interventional cardiology
1,206
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~151 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
379 | $93 | $552 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
250 | $10 | $86 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
163 | $59 | $368 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
136 | $40 | $132 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
101 | $9 | $258 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $116 | $835 |
| Cardiac catheterization | 74 | $194 | $1,543 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $129 | $1,030 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
71 | $88 | $405 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
61 | $49 | $360 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
56 | $142 | $1,056 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
47 | $83 | $530 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
36 | $334 | $2,419 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
27 | $8 | $10 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 22 | $224 | $1,459 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
20 | $69 | $494 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
15 | $449 | $3,090 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
12 | $196 | $1,200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $50 | $380 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
11 | $23 | $600 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
11 | $1,193 | $7,552 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
11 | $146 | $992 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.7% high complexity
20.8% medium
70.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,755
Total received (2018-2024)
Avg $965/year across 7 years
Top 49% in GA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,298 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$456 (6.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,412
2023
$422
2022
$1,579
2021
$1,913
2020
$115
2019
$503
2018
$811
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$279
ABIOMED
$253
Janssen Pharmaceuticals, Inc
$202
Novo Nordisk Inc
$180
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$143
Amgen Inc.
$103
ShockWave Medical, Inc
$90
Novartis Pharmaceuticals Corporation
$46
Kiniksa Pharmaceuticals International, plc
$31
Esperion Therapeutics, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$16
HEARTFLOW, INC.
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 51.9% of 2024 payments
All-time payments by company (2018-2024) ›
Cardiovascular Systems Inc.
$1,135
Abbott Laboratories
$748
ABIOMED
$555
Terumo Medical Corporation
$528
Medtronic, Inc.
$385
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$367
Janssen Pharmaceuticals, Inc
$296
Penumbra, Inc.
$279
Amgen Inc.
$257
Novo Nordisk Inc
$214
Boston Scientific Corporation
$164
CVRx, Inc.
$149
AstraZeneca Pharmaceuticals LP
$147
ASAHI INTECC USA, INC.
$146
CardioFocus, Inc.
$144
Allergan Inc.
$123
SANOFI-AVENTIS U.S. LLC
$120
Shockwave Medical, Inc
$119
Alexion Pharmaceuticals, Inc.
$105
SCPHARMACEUTICALS INC.
$95
ShockWave Medical, Inc
$90
PFIZER INC.
$83
Chiesi USA, Inc.
$75
Novartis Pharmaceuticals Corporation
$46
PORTOLA PHARMACEUTICALS, INC.
$42
Bolton Medical Inc
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Merck Sharp & Dohme LLC
$33
Kiniksa Pharmaceuticals International, plc
$31
E.R. Squibb & Sons, L.L.C.
$31
Teleflex LLC
$27
Inspire Medical Systems, Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$23
Esperion Therapeutics, Inc.
$22
Akcea Therapeutics, Inc.
$20
Impulse Dynamics (USA) Inc.
$19
W. L. Gore & Associates, Inc.
$15
HEARTFLOW, INC.
$15
PORTOLA PHARMACEUTICALS, LLC
$14
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ASAHI PTCA Guide Wire · AVYCAZ · Abre · Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · COREVALVE EVOLUT R · CoreValve Evolut · Diamondback Coronary · Diamondback Peripheral · EKOSONIC · ELIQUIS · ENTRESTO · Emerge Push · Ensite Cardiac Mapping System · FARXIGA · FFRct · FUROSCIX · GENERAL THERAPIES · GLIDESHEATH SLENDER · GORE CARDIOFORM Septal Occluder · Grafts · HeartLight System · HeartMate 3 Left Ventricular Dev · INSPIRE · Impella · Indigo System · JARDIANCE · KENGREAL · LEQVIO · LUX DX · LifeVest · METACROSS OTW · MULTAQ · Manta · Mitra Clip system · NEXLETOL · Optimizer · Optis Coronary Imaging System · Ozempic · Quadra Assura CRT Defibrillator · Quartet CRT Lead · R2P MISAGO · RESOLUTE ONYX · RESONATE · Repatha · Resolute · Rybelsus · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · TR BAND · VERQUVO · VYNDAQEL · WAINUA · Wegovy · XARELTO · Xience Sierra Coronary Stent
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
16
Per 100K population
5.8
County median income
$105,442
Nearest hospital
NORTHSIDE HOSPITAL CHEROKEE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Meleka is a cardiac & electrophysiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Meleka experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Meleka performed 379 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Meleka receive payments from pharmaceutical companies?
Yes. Dr. Meleka received a total of $6,755 from 39 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meleka's costs compare to other interventional cardiologists in Canton?
Dr. Meleka's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meleka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Canton
Browse interventional cardiologists in Canton ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in GA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in GA
Which GA interventional cardiologists receive the most from drug and device companies.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology